The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
AMARIN CORP PLC | SPONS ADR NEW | 023111206 | 22,136,935 | 24,850,623 | SH | SOLE | 24,850,623 | 0 | 0 | ||
BIOCRYST PHARMACEUTICALS INC | COM | 09058V103 | 5,558,373 | 1,094,168 | SH | SOLE | 1,094,168 | 0 | 0 | ||
BIOGEN INC | COM | 09062X103 | 138,650,090 | 643,000 | SH | SOLE | 643,000 | 0 | 0 | ||
CYTOKINETICS INC | COM NEW | 23282W605 | 21,033,000 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
GILEAD SCIENCES INC | COM | 375558103 | 80,815,407 | 1,103,282 | SH | SOLE | 1,103,282 | 0 | 0 | ||
INNOVIVA INC | COM | 45781M101 | 110,901,480 | 7,277,000 | SH | SOLE | 7,277,000 | 0 | 0 | ||
IRONWOOD PHARMACEUTICALS INC | COM CL A | 46333X108 | 142,756,900 | 16,390,000 | SH | SOLE | 16,390,000 | 0 | 0 | ||
NEUROCRINE BIOSCIENCES INC | COM | 64125C109 | 47,779,074 | 346,426 | SH | SOLE | 346,426 | 0 | 0 | ||
REGULUS THERAPEUTICS INC | COM | 75915K309 | 533,327 | 185,183 | SH | SOLE | 185,183 | 0 | 0 | ||
VOR BIOPHARMA INC | COM | 929033108 | 1,464,660 | 618,000 | SH | SOLE | 618,000 | 0 | 0 |